CRSP
#1360
CRISPR Therapeutics AG - Common Shares
50.6 3 USD
-0.05%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-5.10%
Variación mensual
-0.73%
Variación en los últimos 6 meses
-11.03%
Cambio anual
-10.23%
Cierres anteriores
53.3 5
Open
50.6 3
Mínimo
50.6 3
High
50.6 3
Volumen
114
Financials
- Market Capitalization 4.88 B
- Employee 393
- Founded 2013
- CEO Samarth Kulkarni
- Website www.crisprtx.com
- Headquarter Switzerland
- FIGI UNKNOWN
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-8.11
Relación precio/flujo de caja
1 343.5
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1301 |  TVTX Travere Therapeutics, Inc. - Common Stock | 56.29 USD | -0.53% | -2.58% | +6.63% | +95.66% | 5.23 B USD | ||
| 1329 |  CELC Celcuity Inc. - Common Stock | 103.79 USD | -3.52% | -6.02% | +15.36% | +649.39% | 5.06 B USD | ||
| 1372 |  LEGN Legend Biotech Corporation - American Depositary Shares | 25.75 USD | -4.91% | -8.72% | -27.51% | -19.48% | 4.76 B USD | ||
| 1374 |  DFTX Definium Therapeutics, Inc. - Common Shares | 43.65 USD | -7.27% | -1.58% | +76.22% | +188.88% | 4.76 B USD |